Schedule 13G ownership disclosure

LYELL IMMUNOPHARMA INC

Common Stock · CUSIP: 55083R104

Event date: 2024-12-31

Filing-level shares
13,265,869
Percent of class
4.5%
  • BlackRock, Inc.

    Shares: 13,265,869 · Class: 4.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0002012383-25-001224
Form type
SCHEDULE 13G/A
Filer
BlackRock, Inc.
CIK
CIK 2012383
Filed
Feb 05, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub